Bristol-Myers Squibb spol. s r.o.

Supply of Antineoplastic Drugs Containing Nivolumab and Relatlimab

This public procurement contract involves the ongoing supply of pharmaceutical products containing the active ingredients nivolumab and relatlimab. The contract is valued at approximately 129.9 million euros and is intended for the health sector. The buyer is the Faculty Hospital in Olomouc, Czech R